Novast
Latest round
- Series E
Last raised
- May 2020
Total raised
- $166M
Investors
- 10
About Novast
, trading under the name Novast, was founded by Dr. Guohua Zhang, Mr. Prasadraju Pinnamaraju, and a multinational management team. The company focuses on the development of drug-delivery systems and extended-release prescription medications. In 2012, Novast launched Philith™, its first oral contraceptive, into the US market. Since then, the company has filed more than 50 Abbreviated New Drug Applications (ANDAs) with the US FDA, receiving approvals for approximately 40 products, including 10 extended-release drugs. Nearly 40 products have been successfully commercialized in the US prescription drug market.76 billion capsules annually. The company has consistently passed FDA inspections, with five consecutive reviews resulting in no Form 483 observations, and five of its products designated as Reference Standards by the FDA. In 2021, Novast received approvals from China’s NMPA for three high-barrier-entry drugs and passed GMP inspections by the Jiangsu Medical Products Administration. In addition to its own products, Novast partners with multinational pharmaceutical companies, offering contract research and manufacturing services. The company develops and manufactures a portfolio of prescription drugs, with a focus on high-barrier-entry products such as extended-release formulations and ultra-low-dose hormonal drugs. The company generates revenue through the sale of prescription drugs in both domestic and international markets, particularly in the United States. The company plans to continue filing ANDAs with the US FDA, while also broadening its presence in China following recent regulatory approvals.
Who invested in Novast
10 investors across 2 rounds
See all investors in Novast
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Novast
Who invested in Novast?
Novast has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Novast raised?
Novast has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Novast last raise money?
Novast's most recent round on record is a Series E, in May 2020.
What does Novast do?
, trading under the name Novast, was founded by Dr.
Where is Novast headquartered?
Novast is headquartered in Nantong, China.
Which VCs invest in companies like Novast?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Novast's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series E
Raising like Novast? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.